Table 3 Different toplogical indices.
From: Predicting bone cancer drugs properties through topological indices and machine learning
Graphs | Drug name | \(M_1\) | \(M_2\) | FN | \(ND_3\) | \(ND_5\) | NH | NI |
|---|---|---|---|---|---|---|---|---|
\(G_{0}\) | ActinomycinD | 1162 | 329461 | 7606 | 46982 | 212.1012 | 16.6743 | 278.8874 |
\(G_{1}\) | Anastrozole | 264 | 17100 | 1616 | 9456 | 49.85 | 4.1949 | 63.9522 |
\(G_{2}\) | Cabozantinib | 480 | 56816 | 3008 | 18274 | 87.0143 | 7.3764 | 116.9891 |
\(G_{3}\) | Cyclophosphamide | 144 | 5040 | 848 | 4828 | 30.3167 | 3.0851 | 34.6277 |
\(G_{4}\) | Doxorubicin | 550 | 74104 | 3816 | 25474 | 94.8679 | 7.1905 | 132.5252 |
\(G_{5}\) | Etoposide | 604 | 90115 | 4052 | 26682 | 102.271 | 8.0812 | 147.4245 |
\(G_{6}\) | Gemcitabine | 232 | 13132 | 1552 | 9792 | 42.2075 | 3.3285 | 55.5364 |
\(G_{7}\) | Ibandronate | 202 | 9717 | 1330 | 7774 | 40.4366 | 3.5539 | 47.3827 |
\(G_{8}\) | Ifosfamide | 144 | 5040 | 848 | 4844 | 30.1833 | 3.093 | 34.6892 |
\(G_{9}\) | Letrozole | 262 | 16905 | 1536 | 8928 | 50.4429 | 4.6634 | 64.1327 |
\(G_{10}\) | Pazopanib | 404 | 40228 | 2522 | 15046 | 72.3321 | 5.8765 | 98.357 |
\(G_{11}\) | Regorafenib | 390 | 37496 | 2288 | 12932 | 74.0571 | 6.5007 | 95.1728 |
\(G_{12}\) | Sorafenib | 374 | 34528 | 2160 | 12066 | 71.4952 | 6.3829 | 91.4764 |
\(G_{13}\) | Tamoxifen | 316 | 24640 | 1810 | 10462 | 62.4611 | 6.0734 | 77.5096 |
\(G_{14}\) | Zoledronicacid | 196 | 9163 | 1358 | 8360 | 35.8561 | 2.7695 | 46.1692 |
